The Oncology Institute · 2 days ago
Hematologist Oncologist Orlando FL
Orlando, Florida, United States
Full-time
Onsite
Senior LevelThe Oncology Institute is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. They are seeking a dedicated and compassionate Hematologist/Oncologist to provide personalized care for patients with hematologic and oncologic conditions while collaborating with a team to develop individualized treatment plans.
Health CareHealth DiagnosticsHome Health CareMedicalOncologyPsychology
Responsibilities
Provide personalized care for patients with hematologic and oncologic conditions
Collaborate with a team of oncologists to develop and implement individualized treatment plans
Participate in case discussions, and ongoing education initiatives
Engage in community outreach to enhance cancer care awareness and support
Qualification
Required
Board Certified/Board Eligible in Hematology and Oncology
Eligible for medical licensure in Florida
Commitment to patient-centered care and strong clinical skills
Benefits
Access to Clinical Trials & Research Opportunities
Clinical Autonomy
Patient-Centered Care
Technology & Resources
Career Development & Advancement
Work-Life Balance
Comprehensive benefits package including medical, dental, vision, matching 401(k), CME allowance, and pet insurance.
Company
The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting.
Founded in 2007
501-1000 employees
H1B Sponsorship
The Oncology Institute has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (1)
Funding
Current Stage
Public CompanyTotal Funding
$291.5MKey Investors
Deerfield
2025-03-24Post Ipo Equity· $16.5M
2021-11-15Post Ipo Equity· $275M
2021-11-15IPO
Leadership Team
Daniel Virnich
Board Member
Jeffrey Langsam
Chief Clinical Officer
Recent News
2026-01-11
2026-01-10
2026-01-05
Company data provided by crunchbase